A key challenge on the horizon that investors are facing in 2017 is the prospect of continual rises in interest rates.
In March 2017, the Federal Reserve raised interest rates by 25bps to 0.75%, and indicated two further increases in the coming 12 months. While rising interest rates in the US places pressure on fixed...
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds